Reg-ent℠ Advocacy Efforts
In addition to serving as the first and only national repository of otolaryngology specific data, Reg-ent also actively advocates for our members on issues related to quality data reporting, data access, and interoperability. In collaboration with the AAO-HNS Advocacy team and the Physician Clinical Registry Coalition, Reg-ent has submitted comments and joint letters to CMS, the Office of the National Coordinator (ONC), and Congressional leadership addressing information blocking by EHR vendors and the burden of Medicare reporting requirements on physicians.
AAO-HNS Comment Letter
On September 10, the AAO-HNS submitted a comment letter to the Centers for Medicare & Medicaid Services (CMS) addressing several components of the Proposed CY 2019 Physician Fee Schedule and Changes to Quality Payment Program (QPP). Comments specific to Qualified Clinical Data Registries (QCDR), MIPS reporting, and Quality Measures start on page 20. Click here to read the letter.
Physician Clinical Registry Coalition
Reg-ent is a member of the Physician Clinical Registry Coalition (PCRC), which is a group made up of various medical and surgical society-sponsored, physician-led, or physician-centric registries that are dedicated to improving quality of care through the collection, analysis, and sharing of information on clinical data outcomes. The PCRC also advocates on behalf of clinical data registries. Learn more about the PCRC here.
- AAO-HNSF signed on to the PCRC comment letter on the proposed rule changes to the CY 2019 Physician Fee Schedule and Changes to Quality Payment Program (QPP). Click here to read the letter.
- AAO-HNSF signed on to the PCRC letter to HHS regarding information blocking by Electronic Health Record vendors. Click here to read the letter.
- AAO-HNSF signed on to the PCRC response to the request for information (RFI) from the ONC regarding the 21st Century Cures Act Electronic Health Reporting Program. Click here to read the letter.
- AAO-HNSF signed on to the PCRC letter to CMS about concerns regarding Qualified Clinical Data Registries and MIPS. Click here to read the letter.